History and Perspectives of A2A Adenosine Receptor Antagonists as Potential Therapeutic Agents

E-ISSN： 1098-1128|35|4|790-848

ISSN： 0198-6325

Source： MEDICINAL RESEARCH REVIEWS, Vol.35, Iss.4, 2015-07, pp. : 790-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives

JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol. 70, Iss. 2, 2018-02 ,pp. : 191-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Anticancer Potential of Peroxisome Proliferator‐Activated Receptor Antagonists

CHEMMEDCHEM, Vol. 13, Iss. 3, 2018-02 ,pp. : 209-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potent, Metabolically Stable 2‐Alkyl‐8‐(2H‐1,2,3‐triazol‐2‐yl)‐9H‐adenines as Adenosine A2A Receptor Ligands

CHEMMEDCHEM, Vol. 10, Iss. 7, 2015-07 ,pp. : 1149-1152

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of (4‐Arylpiperidin‐1‐yl)cyclopentanecarboxamides As High‐Affinity and Long‐Residence‐Time Antagonists for the CCR2 Receptor

CHEMMEDCHEM, Vol. 10, Iss. 7, 2015-07 ,pp. : 1249-1258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sigma‐2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy

MEDICINAL RESEARCH REVIEWS, Vol. 34, Iss. 3, 2014-05 ,pp. : 532-566

John Wiley & Sons Inc

Access to resources Recommend Favorite